vs
AtriCure, Inc.（ATRC）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
AtriCure, Inc.的季度营收约是REPUBLIC BANCORP INC的1.5倍（$140.5M vs $94.3M），AtriCure, Inc.同比增速更快（13.1% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $18.4M），过去两年AtriCure, Inc.的营收复合增速更高（13.6% vs -11.5%）
AtriCure是一家专注于心房颤动及相关心脏病症治疗的医疗设备企业，研发并生产创新外科手术工具与疗法，主要服务北美、欧洲、亚太地区的医院、心脏外科中心及医疗机构，为微创心脏手术提供高效可靠的适配解决方案。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
ATRC vs RBCAA — 直观对比
营收规模更大
ATRC
是对方的1.5倍
$94.3M
营收增速更快
ATRC
高出7.7%
5.3%
自由现金流更多
RBCAA
多$142.7M
$18.4M
两年增速更快
ATRC
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $140.5M | $94.3M |
| 净利润 | — | $22.8M |
| 毛利率 | 75.0% | — |
| 营业利润率 | 1.8% | 29.3% |
| 净利率 | — | 24.2% |
| 营收同比 | 13.1% | 5.3% |
| 净利润同比 | — | 20.0% |
| 每股收益（稀释后） | $0.04 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRCRBCAA
| Q4 25 | $140.5M | $94.3M | ||
| Q3 25 | $134.3M | $93.5M | ||
| Q2 25 | $136.1M | $93.8M | ||
| Q1 25 | $123.6M | $135.8M | ||
| Q4 24 | $124.3M | $89.5M | ||
| Q3 24 | $115.9M | $88.1M | ||
| Q2 24 | $116.3M | $86.9M | ||
| Q1 24 | $108.9M | $120.3M |
净利润ATRCRBCAA
| Q4 25 | — | $22.8M | ||
| Q3 25 | $-267.0K | $29.7M | ||
| Q2 25 | $-6.2M | $31.5M | ||
| Q1 25 | $-6.7M | $47.3M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $-7.9M | $26.5M | ||
| Q2 24 | $-8.0M | $25.2M | ||
| Q1 24 | $-13.3M | $30.6M |
毛利率ATRCRBCAA
| Q4 25 | 75.0% | — | ||
| Q3 25 | 75.5% | — | ||
| Q2 25 | 74.5% | — | ||
| Q1 25 | 74.9% | — | ||
| Q4 24 | 74.5% | — | ||
| Q3 24 | 74.9% | — | ||
| Q2 24 | 74.7% | — | ||
| Q1 24 | 74.7% | — |
营业利润率ATRCRBCAA
| Q4 25 | 1.8% | 29.3% | ||
| Q3 25 | 0.2% | 40.4% | ||
| Q2 25 | -4.5% | 43.0% | ||
| Q1 25 | -4.8% | 44.1% | ||
| Q4 24 | -11.7% | 25.8% | ||
| Q3 24 | -6.4% | 38.4% | ||
| Q2 24 | -6.2% | 37.0% | ||
| Q1 24 | -10.0% | 32.2% |
净利率ATRCRBCAA
| Q4 25 | — | 24.2% | ||
| Q3 25 | -0.2% | 31.8% | ||
| Q2 25 | -4.5% | 33.5% | ||
| Q1 25 | -5.5% | 34.8% | ||
| Q4 24 | — | 21.2% | ||
| Q3 24 | -6.8% | 30.1% | ||
| Q2 24 | -6.9% | 29.0% | ||
| Q1 24 | -12.2% | 25.4% |
每股收益（稀释后）ATRCRBCAA
| Q4 25 | $0.04 | — | ||
| Q3 25 | $-0.01 | — | ||
| Q2 25 | $-0.13 | — | ||
| Q1 25 | $-0.14 | — | ||
| Q4 24 | $-0.33 | — | ||
| Q3 24 | $-0.17 | — | ||
| Q2 24 | $-0.17 | — | ||
| Q1 24 | $-0.28 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.4M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $491.9M | $1.1B |
| 总资产 | $654.2M | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ATRCRBCAA
| Q4 25 | $167.4M | $220.0M | ||
| Q3 25 | $147.9M | $484.2M | ||
| Q2 25 | $117.8M | $484.8M | ||
| Q1 25 | $99.9M | $793.0M | ||
| Q4 24 | $122.7M | $432.2M | ||
| Q3 24 | $130.3M | $530.9M | ||
| Q2 24 | $114.0M | $400.1M | ||
| Q1 24 | $106.0M | $546.4M |
总债务ATRCRBCAA
| Q4 25 | — | — | ||
| Q3 25 | $61.9M | — | ||
| Q2 25 | $61.9M | — | ||
| Q1 25 | $61.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $61.9M | — | ||
| Q2 24 | $61.9M | — | ||
| Q1 24 | $61.9M | — |
股东权益ATRCRBCAA
| Q4 25 | $491.9M | $1.1B | ||
| Q3 25 | $476.5M | $1.1B | ||
| Q2 25 | $464.5M | $1.1B | ||
| Q1 25 | $454.6M | $1.0B | ||
| Q4 24 | $461.0M | $992.0M | ||
| Q3 24 | $465.0M | $979.7M | ||
| Q2 24 | $462.1M | $955.4M | ||
| Q1 24 | $456.3M | $935.6M |
总资产ATRCRBCAA
| Q4 25 | $654.2M | $7.0B | ||
| Q3 25 | $635.4M | $7.0B | ||
| Q2 25 | $608.8M | $7.0B | ||
| Q1 25 | $591.6M | $7.1B | ||
| Q4 24 | $609.3M | $6.8B | ||
| Q3 24 | $615.1M | $6.7B | ||
| Q2 24 | $597.3M | $6.6B | ||
| Q1 24 | $591.6M | $6.9B |
负债/权益比ATRCRBCAA
| Q4 25 | — | — | ||
| Q3 25 | 0.13× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.0M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $18.4M | $161.1M |
| 自由现金流率自由现金流/营收 | 13.1% | 170.9% |
| 资本支出强度资本支出/营收 | 1.1% | 7.5% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | $48.3M | $288.6M |
8季度趋势，按日历期对齐
经营现金流ATRCRBCAA
| Q4 25 | $20.0M | $168.2M | ||
| Q3 25 | $26.7M | $33.3M | ||
| Q2 25 | $21.6M | $8.4M | ||
| Q1 25 | $-11.0M | $93.2M | ||
| Q4 24 | $5.8M | $149.0M | ||
| Q3 24 | $20.0M | $51.3M | ||
| Q2 24 | $7.4M | $4.0M | ||
| Q1 24 | $-21.0M | $71.2M |
自由现金流ATRCRBCAA
| Q4 25 | $18.4M | $161.1M | ||
| Q3 25 | $24.1M | $30.8M | ||
| Q2 25 | $19.0M | $5.2M | ||
| Q1 25 | $-13.2M | $91.6M | ||
| Q4 24 | $3.1M | $143.2M | ||
| Q3 24 | $16.4M | $49.8M | ||
| Q2 24 | $5.0M | $2.7M | ||
| Q1 24 | $-23.8M | $69.1M |
自由现金流率ATRCRBCAA
| Q4 25 | 13.1% | 170.9% | ||
| Q3 25 | 18.0% | 32.9% | ||
| Q2 25 | 13.9% | 5.5% | ||
| Q1 25 | -10.7% | 67.4% | ||
| Q4 24 | 2.5% | 160.0% | ||
| Q3 24 | 14.1% | 56.5% | ||
| Q2 24 | 4.3% | 3.1% | ||
| Q1 24 | -21.9% | 57.5% |
资本支出强度ATRCRBCAA
| Q4 25 | 1.1% | 7.5% | ||
| Q3 25 | 1.9% | 2.6% | ||
| Q2 25 | 2.0% | 3.5% | ||
| Q1 25 | 1.8% | 1.2% | ||
| Q4 24 | 2.2% | 6.5% | ||
| Q3 24 | 3.1% | 1.7% | ||
| Q2 24 | 2.1% | 1.5% | ||
| Q1 24 | 2.5% | 1.7% |
现金转化率ATRCRBCAA
| Q4 25 | — | 7.37× | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRC
| Appendage Management | $45.5M | 32% |
| Openheart | $38.5M | 27% |
| Other | $26.2M | 19% |
| Pain Management | $22.6M | 16% |
| Minimally Invasive | $7.7M | 6% |
RBCAA
暂无分部数据
